Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Long Term Evaluation of Activity Levels Post Pulmonary Rehabilitation: 1 Year Follow-up
| Verified date | February 2012 |
| Source | Beaumont Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Ireland: Medical Ethics Research Committee |
| Study type | Interventional |
Sustained improvement after pulmonary rehabilitation in activity levels as measured by an
activity armband.
Pulmonary rehabilitation is utilized to improve exercise capacity, quality of life and
prognosis for patients who suffer from chronic obstructive pulmonary disease. There is also
strong evidence that supports the use of pulmonary rehabilitation to decrease hospital
admissions thereby reducing cost of care. Recent studies suggest that the significant
benefits achieved through rehabilitation fade with time and that in order to improve
activities of daily living; for example, average daily number of steps, programmes of longer
duration are required.
The primary aim of this study is to identify objective sustained improved in activity levels
using the SenseWear activity armband after a short-term pulmonary rehabilitation programme.
Secondary aims are to determine antibiotic and steroid use pre and post rehabilitation.
| Status | Completed |
| Enrollment | 65 |
| Est. completion date | July 2010 |
| Est. primary completion date | July 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 35 Years and older |
| Eligibility |
Inclusion Criteria: - A diagnosis of COPD based on the GOLD staging of the disease - Referred to pulmonary rehabilitation by a respiratory consultant or member of the COPD Team - Modified Medical Research Council Score of 3 or above - Ability to mobilize independently - Motivated to exercise independently Exclusion Criteria: - No evidence of COPD on spirometry - Acute exacerbation within the last 4-6 weeks - Evidence of ischemic heart disease/acute changes on ECG - Uncontrolled hypertension - Insulin dependent diabetes mellitus - Inability to exercise independently or musculoskeletal/neurological conditions which would prevent completion of the course - Lung cancer previous attendance at pulmonary rehabilitation |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| Ireland | Beaumont Hospital | Beaumont | Dublin |
| Lead Sponsor | Collaborator |
|---|---|
| Beaumont Hospital |
Ireland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Sustained improvement in free-living activities, measured as the average daily METs | Using an accelerometer, which will be worn by patients for seven consecutive days at each time frame, daily average measurements of the number of steps per day, total energy expenditure and METs that will be broken down into sedentary, moderate and vigorous, plus sleep time and efficiency. | At the end of 1 year compared to baseline | No |
| Secondary | Quality of Life | Two quality of life questionnaires will be utilized, 1) the St. Georges Disease Questionnaire; a disease specific questionnaire, 2)The generic EuroQol questionnaire | baseline will be compared to that at 1 year follow-up | No |
| Secondary | The Incremental Shuttle Walk Test | This is a validated field exercise test used to prescribe exercise intensity and determine functional capacity | baseline will be compared to that at 1 year follow-up | No |
| Secondary | The Modified Medical Research Council Scale | This questionnaire measures breathlessness on activity | baseline will be compared to that at 1 year follow-up | No |
| Secondary | Pulmonary Function Tests | Measurements of forced expiratory volume in 1 second, Forced Vital Capacity, Inspiratory Capacity and peak inspiratory muscle pressure will all be measured | baseline will be compared to that at 1 year follow-up | No |
| Secondary | Borg Score | A 10 point scale measurement of breathlessness | baseline will be compared to that at 1 year follow-up | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
| Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
| Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
| Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
| Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
| Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
| Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
| Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
| Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
| Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
| Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
| Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
| Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
| Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
| Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
| Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|